French Prospective Observational Study in Patients Eligible for Systemic Therapy for Atopic Dermatitis (AD)

Last updated: February 14, 2025
Sponsor: Sanofi
Overall Status: Active - Recruiting

Phase

N/A

Condition

Atopic Dermatitis

Allergies & Asthma

Eczema (Atopic Dermatitis)

Treatment

N/A

Clinical Study ID

NCT06837454
OBS17667
U1111-1279-3382
  • Ages > 18
  • All Genders

Study Summary

The objective of the study is to describe the therapeutic management of patients more than or equal to 18 years old eligible for systemic therapy or treated by systemic therapy for atopic dermatitis (AD). This study will be proposed to a sample of French dermatologists experienced in the management of AD, practicing in hospital centers and/or office-based dermatologists. The study will be conducted in real conditions of practice, systemic treatment decisions will be taken at the sole initiative of the participating physician irrespective of the patient enrollment decision. Each patient will be followed-up in routine care setting for 1 year.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Signed informed consent form.

  • Patient with moderate to severe AD according to the Investigator's judgment and

  1. Patient eligible to systemic treatment as Atopic Dermatitis Control Tool (ADCT)more than or equal to (≥) 7 and/or use topical corticosteroids (TCS) more than (>) 90 gram (g)/month and/or TCS are not advisable.or

  2. Patient currently under systemic treatment.

  • Able to understand and complete study-related questionnaires.

Exclusion

Exclusion Criteria:

  • Any condition that, in the opinion of the Investigator, may interfere with patient'sability to participate in the study, such as short life expectancy, substance abuse,severe cognitive impairment, or other comorbidities that can predictably prevent thepatient from adequately completing, as per routine care, the schedule of visits andassessments

  • Patient receiving systemic therapy only for a disease other than AD.

  • Patient participating in any interventional clinical trial at the time of enrolment.

  • Patient is under tutorship or curatorship; patient under safeguard of justice ordeprived of his/her liberty by an administrative or court decision

Study Design

Total Participants: 600
Study Start date:
February 04, 2025
Estimated Completion Date:
April 09, 2027

Connect with a study center

  • Investigational Site Number 00001

    Le Puy-en-Velay, 43000
    France

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.